You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

E7386

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial in Leeds (E7386 Tablet, (14C)E7386 Capsule, (14C)E7386)

Recruiting
  • Healthy Volunteers
  • E7386 Tablet
  • +2 more
  • Leeds, United Kingdom
    Labcorp Clinical Research Unit
Oct 31, 2022

Advanced Tumors Trial in Glasgow, Manchester, Sutton (E7386)

Recruiting
  • Advanced Neoplasms
  • E7386
  • Glasgow, Lanarkshire, United Kingdom
  • +2 more
Nov 30, 2022

Healthy Volunteers Trial in Nottingham (E7386)

Suspended
  • Healthy Volunteers
  • E7386
  • Nottingham, United Kingdom
    Quotient Sciences
May 19, 2022

Solid Tumors, Colorectal Tumors, Gastrointestinal Tumors Trial in Japan (E7386)

Active, not recruiting
  • Solid Neoplasms
  • +2 more
  • E7386
  • Kashiwa, Chiba, Japan
  • +3 more
Jul 20, 2022

Tumors, Carcinoma, Hepatocellular, Liver Tumors Trial in Japan (E7386, Lenvatinib)

Recruiting
  • Neoplasms
  • +2 more
  • Kashiwa, Chiba, Japan
  • +2 more
Nov 8, 2021

Food Effect in Healthy Participants Trial in Austin (E7386)

Completed
  • Food Effect in Healthy Participants
  • E7386
  • Austin, Texas
    PPD
Nov 13, 2019

Bladder Cancer Trial in United States (N-803 and BCG, N-803)

Recruiting
  • Bladder Cancer
  • Anchorage, Alaska
  • +31 more
Oct 26, 2022

Pneumocystis, Pneumocystis Pneumonia, Pneumocystis Jirovecii Infection Trial in Montreal (trimethoprim-sulfamethoxazole)

Not yet recruiting
  • Pneumocystis
  • +7 more
  • Montreal, Quebec, Canada
    McGill University Health Centre (Royal Victoria Hospital and Mon
Apr 5, 2022

Type 1 Diabetes Trial in Bronx (Exenatide, Rapid and long acting insulin, long acting insulin + rapid acting + 1.25 mcg

Completed
Has Results
  • Type 1 Diabetes
  • Bronx, New York
    Albert Einstein CRC- West Campus
Jul 13, 2021

Post Acute COVID-19 Syndrome, Long COVID, Long Covid19 Trial in New York (stellate ganglion block with 0.5% bupivacaine)

Recruiting
  • Post Acute COVID-19 Syndrome
  • +14 more
  • stellate ganglion block with 0.5% bupivacaine
  • New York, New York
    Hudson Medical
Jan 10, 2023

Stage IB-IIIA Non-small Cell Lung Carcinoma Trial in Worldwide (AZD9291 80 mg/40 mg, Placebo AZD9291 80 mg/40 mg, Open-label

Active, not recruiting
Has Results
  • Stage IB-IIIA Non-small Cell Lung Carcinoma
  • AZD9291 80 mg/40 mg
  • +2 more
  • Los Angeles, California
  • +240 more
Jan 12, 2023

Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

Recruiting
  • Pancreatic Cancer
  • +49 more
    • Colorado Springs, Colorado
    • +80 more
    Feb 22, 2022

    Smoking Trial in New York (Telephone Care Coordination, Telephone Care Coordination with state Quitline)

    Completed
    Has Results
    • Smoking
    • Telephone Care Coordination
    • Telephone Care Coordination with state Quitline
    • New York, New York
      Manhattan Campus of the VA NY Harbor Healthcare System, New York
    Oct 27, 2020

    Severe Acute Respiratory Syndrome, Coronavirus, SARS-CoV-2 Trial in Belgium, Germany (CVnCoV Vaccine, Placebo)

    Completed
    Has Results
    • Severe Acute Respiratory Syndrome
    • +3 more
    • CVnCoV Vaccine
    • Placebo
    • Ghent, Belgium
    • +3 more
    Apr 29, 2022

    Prostatic Tumors Trial in Kfar-Saba (PectaSol-C Modified Citrus Pectin (MCP))

    Completed
    • Prostatic Neoplasms
    • PectaSol-C Modified Citrus Pectin (MCP)
    • Kfar-Saba, Israel
      Genitourinary Oncology Service, Institute of Oncology, Meir Medi
    Jan 27, 2020

    Cystitis, Interstitial Trial in Worldwide (Tanezumab, Placebo)

    Terminated
    Has Results
    • Cystitis, Interstitial
    • Tanezumab
    • Placebo
    • Mobile, Alabama
    • +170 more
    Jul 12, 2021

    Smoking Trial in United States (Proactive outreach, Usual care)

    Completed
    Has Results
    • Smoking
    • Proactive outreach
    • Usual care
    • Tampa, Florida
    • +3 more
    Mar 18, 2019

    HIV/AIDS Trial in Baltimore (CASA Education)

    Completed
    Has Results
    • HIV/AIDS
    • CASA Education
    • Baltimore, Maryland
      University of Maryland Medical System
    May 23, 2019

    Systemic Lupus Erythematosus Trial in United States (CC-220, Placebo)

    Completed
    Has Results
    • Systemic Lupus Erythematosus
    • Birmingham, Alabama
    • +34 more
    Mar 5, 2020

    Arthritis, Rheumatoid Trial in Cambridge (Cantharidin, Lipopolysaccharide, Granulocyte-Macrophage Colony-Stimulating Factor)

    Completed
    Has Results
    • Arthritis, Rheumatoid
    • Cantharidin
    • +3 more
    • Cambridge, United Kingdom
      GSK Investigational Site
    Jun 17, 2019

    Psoriasis Trial in Worldwide (80 mg Ixekizumab Dosing Regimens 1, 2, and 3, Placebo)

    Completed
    Has Results
    • Psoriasis
    • 80 mg Ixekizumab Dosing Regimens 1, 2, and 3
    • Placebo
    • Birmingham, Alabama
    • +103 more
    Sep 17, 2019

    Urea Cycle Disorder Trial in Canada, United States (RAVICTI)

    Completed
    Has Results
    • Urea Cycle Disorder
    • Los Angeles, California
    • +16 more
    Feb 8, 2019

    Clostridium Enterocolitis, Pseudomembranous Colitis Trial in Houston (Nitazoxanide)

    Completed
    Has Results
    • Clostridium Enterocolitis
    • Pseudomembranous Colitis
    • Houston, Texas
    • +1 more
    May 8, 2017

    Kidney Failure, Chronic Trial in Indianapolis (LY2127399)

    Completed
    Has Results
    • Kidney Failure, Chronic
    • Indianapolis, Indiana
      For additional information regarding investigative sites for thi
    May 11, 2018

    Demonstrating Clinical and Economic Benefit of 5 Alpha Reductase

    Completed
    Has Results
    • Prostatic Hyperplasia
    • Adherent with 5-alpha-reductase inhibitor (5ARI) therapy
    • Non-adherent to 5ARI therapy
    • (no location specified)
    May 25, 2017